Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2019-02-26 Tx date 2019-02-25 |
$PLI
Prometic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-85,301 vol |
228,307 | |
Filed 2019-02-26 Tx date 2019-02-25 |
$PLI
Prometic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: REER (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+85,301 vol |
276,011 | |
Filed 2019-01-04 Tx date 2019-01-02 |
$PLI
Prometic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,098
+21,400 vol $0.285 each |
34,678 | |
Filed 2018-12-17 Tx date 2018-12-14 |
$PLI
Prometic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-68,000
-200,000 vol $0.34 each |
527,753 | |
Filed 2018-12-07 Tx date 2018-12-04 |
$PLI
Prometic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$139,999
+181,818 vol $0.77 each |
727,753 | |
Filed 2018-05-23 Tx date 2018-05-23 |
$PLI
Prometic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: REER (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+33,172 vol |
190,710 | |
Filed 2018-05-23 Tx date 2018-05-23 |
$PLI
Prometic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-33,172 vol |
320,398 | |
Filed 2018-05-23 Tx date 2018-05-23 |
$PLI
Prometic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-6,790 vol |
313,608 | |
Filed 2018-05-23 Tx date 2018-05-23 |
$PLI
Prometic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+6,790 vol |
13,278 | |
Filed 2017-08-28 Tx date 2017-08-18 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-25,940 vol |
347,170 | |
Filed 2017-08-28 Tx date 2017-08-18 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-26,940 vol |
||
Filed 2017-08-23 Tx date 2017-08-18 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+4,621 vol |
6,488 | |
Filed 2017-08-23 Tx date 2017-08-18 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+5,621 vol |
||
Filed 2017-08-22 Tx date 2017-08-18 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: REER (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+21,319 vol |
157,538 | |
Filed 2017-08-22 Tx date 2017-08-18 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-26,940 vol |
346,170 | |
Filed 2017-08-22 Tx date 2017-08-18 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,680
+6,400 vol $1.20 each |
352,570 | |
Filed 2017-08-22 Tx date 2017-08-18 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+5,621 vol |
7,488 | |
Filed 2017-07-11 Tx date 2017-07-10 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$24,000
+200,000 vol $0.12 each |
455,312 | |
Filed 2017-07-11 Tx date 2017-07-10 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-131,342.3556
-82,202 vol $1.60 each |
373,110 | |
Filed 2017-07-11 Tx date 2017-07-10 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,000
-200,000 vol $0.12 each |
545,935 | |
Filed 2017-05-23 Tx date 2017-05-18 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$143,579
+69,362 vol $2.07 each |
745,935 | |
Filed 2017-01-29 Tx date 2017-01-24 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-22,500
-150,000 vol $0.15 each |
676,573 | |
Filed 2017-01-29 Tx date 2017-01-24 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$22,500
+150,000 vol $0.15 each |
316,200 | |
Filed 2017-01-29 Tx date 2017-01-24 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-130,300.32
-60,888 vol $2.14 each |
255,312 | |
Filed 2016-11-25 Tx date 2016-11-25 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,700
+10,000 vol $2.47 each |
166,200 | |
Filed 2016-08-29 Tx date 2016-08-26 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,500
+50,000 vol $0.15 each |
206,200 | |
Filed 2016-08-29 Tx date 2016-08-26 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-142,700
-50,000 vol $2.85 each |
156,200 | |
Filed 2016-08-29 Tx date 2016-08-26 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-7,500
-50,000 vol $0.15 each |
826,573 | |
Filed 2016-05-30 Tx date 2016-05-25 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$186,612
+62,204 vol $3.00 each |
876,573 | |
Filed 2016-01-13 Tx date 2009-05-06 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-01-13 Tx date 2016-01-12 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: CELI (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,488
+1,867 vol $2.94 each |
1,867 | |
Filed 2016-01-04 Tx date 2015-12-31 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$745.80
+220 vol $3.39 each |
156,000 | |
Filed 2016-01-04 Tx date 2015-12-31 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Holder: REER (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$391.00
+115 vol $3.40 each |
136,219 | |
Filed 2016-01-04 Tx date 2015-12-31 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$676.00
+200 vol $3.38 each |
156,200 | |
Filed 2015-06-12 Tx date 2015-06-08 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+80,710 vol |
814,369 | |
Filed 2015-06-12 Tx date 2015-06-11 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,500
+10,000 vol $2.35 each |
155,780 | |
Filed 2015-06-05 Tx date 2015-06-04 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-120,000
-50,000 vol $2.40 each |
145,780 | |
Filed 2015-06-05 Tx date 2015-06-04 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,000
+50,000 vol $0.18 each |
195,780 | |
Filed 2015-06-05 Tx date 2015-06-04 |
$PLI
ProMetic Life Sciences Inc. |
Ménard, Louise
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,000
-50,000 vol $0.18 each |
733,659 |